» Articles » PMID: 18026104

Loss of Trim24 (Tif1alpha) Gene Function Confers Oncogenic Activity to Retinoic Acid Receptor Alpha

Overview
Journal Nat Genet
Specialty Genetics
Date 2007 Nov 21
PMID 18026104
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is a major cause of death worldwide. Here, we provide evidence that the ligand-dependent nuclear receptor co-regulator Trim24 (also known as Tif1alpha) functions in mice as a liver-specific tumor suppressor. In Trim24-null mice, hepatocytes fail to execute proper cell cycle withdrawal during the neonatal-to-adult transition and continue to cycle in adult livers, becoming prone to a continuum of cellular alterations that progress toward metastatic HCC. Using pharmacological approaches, we show that inhibition of retinoic acid signaling markedly reduces hepatocyte proliferation in Trim24-/- mice. We further show that deletion of a single retinoic acid receptor alpha (Rara) allele in a Trim24-null background suppresses HCC development and restores wild-type expression of retinoic acid-responsive genes in the liver, thus demonstrating that in this genetic background Rara expresses an oncogenic activity correlating with a dysregulation of the retinoic acid signaling pathway. Our results not only provide genetic evidence that Trim24 and Rara co-regulate hepatocarcinogenesis in an antagonistic manner but also suggest that aberrant activation of Rara is deleterious to liver homeostasis.

Citing Articles

Cryo-EM structure of PML RBCC dimer reveals CC-mediated octopus-like nuclear body assembly mechanism.

Tan Y, Li J, Zhang S, Zhang Y, Zhuo Z, Ma X Cell Discov. 2024; 10(1):118.

PMID: 39587079 PMC: 11589706. DOI: 10.1038/s41421-024-00735-3.


The Immune Modulatory Role of TIF1 Proteins.

Zhu Q, Xiao Y Adv Exp Med Biol. 2024; 1466:89-99.

PMID: 39546137 DOI: 10.1007/978-981-97-7288-9_6.


The tripartite motif-containing 24 is a multifunctional player in human cancer.

Yao Y, Zhou S, Yan Y, Fu K, Xiao S Cell Biosci. 2024; 14(1):103.

PMID: 39160596 PMC: 11334367. DOI: 10.1186/s13578-024-01289-3.


History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies.

Bercier P, de The H Cancers (Basel). 2024; 16(7).

PMID: 38611029 PMC: 11011038. DOI: 10.3390/cancers16071351.


TRIM5 as a promising diagnostic biomarker of hepatocellular carcinoma: integrated analysis and experimental validation.

Liu H, Tang Y, Zhang J, Wu G, Peng Q, Chen C Funct Integr Genomics. 2024; 24(2):63.

PMID: 38517555 DOI: 10.1007/s10142-024-01339-6.